These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 6122239

  • 1. The transport and turnover of phospholipids in the rat nigrostriatal system: effects of d-amphetamine and haloperidol.
    Hitzemann R, Loh H.
    Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):209-28. PubMed ID: 6122239
    [Abstract] [Full Text] [Related]

  • 2. Role of striatal dopamine in the lordosis behaviour.
    Pednekar JR, Mascarenhas JF.
    Indian J Physiol Pharmacol; 1993 Oct; 37(4):333-6. PubMed ID: 8112812
    [Abstract] [Full Text] [Related]

  • 3. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK, Nash JF, Gudelsky GA.
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [Abstract] [Full Text] [Related]

  • 4. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
    Robinson TE, Noordhoorn M, Chan EM, Mocsary Z, Camp DM, Whishaw IQ.
    Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with D-amphetamine.
    Nowak P, Kostrzewa RM, Kwieciński A, Bortel A, Labus Ł, Brus R.
    J Physiol Pharmacol; 2005 Jun; 56(2):325-33. PubMed ID: 15985712
    [Abstract] [Full Text] [Related]

  • 7. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B, Kozlowski DA, Unnerstall JR, Elsworth JD, Tillerson JL, Schallert T, Bohn MC.
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [Abstract] [Full Text] [Related]

  • 8. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ, György L.
    Acta Physiol Acad Sci Hung; 1981 May; 58(3):225-33. PubMed ID: 7348023
    [Abstract] [Full Text] [Related]

  • 9. Nigrostriatal cell firing action on the dopamine transporter.
    Rodriguez M, Gonzalez S, Morales I, Sabate M, Gonzalez-Hernandez T, Gonzalez-Mora JL.
    Eur J Neurosci; 2007 May; 25(9):2755-65. PubMed ID: 17561841
    [Abstract] [Full Text] [Related]

  • 10. Effect of ethanol on mouse brain microsomal phospholipid turnover.
    Natsuki R.
    Arukoru Kenkyuto Yakubutsu Ison; 1992 Oct; 27(5):509-18. PubMed ID: 1449410
    [Abstract] [Full Text] [Related]

  • 11. Effects of para-chlorophenylalanine on amphetamine and haloperidol-induced changes in striatal dopamine turnover.
    Kuczenski R.
    Brain Res; 1979 Mar 23; 164():217-25. PubMed ID: 154937
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
    Connor B, Kozlowski DA, Schallert T, Tillerson JL, Davidson BL, Bohn MC.
    Gene Ther; 1999 Dec 23; 6(12):1936-51. PubMed ID: 10637445
    [Abstract] [Full Text] [Related]

  • 13. Increases of substance P-like immunoreactivity within striatal-nigral structures after subacute methamphetamine treatment.
    Ritter JK, Schmidt CJ, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1984 May 23; 229(2):487-92. PubMed ID: 6201607
    [Abstract] [Full Text] [Related]

  • 14. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA, Weiner N.
    J Pharmacol Exp Ther; 1995 Oct 23; 275(1):237-44. PubMed ID: 7562556
    [Abstract] [Full Text] [Related]

  • 15. [Transplantation of fetal dopaminergic cells simultaneously to the corpus striatum and pars reticularis of the substantia nigra in hemi-parkinsonian rats].
    Blanco L, Pavón N, Alvaŕez P, Díaz C, Castellano O, Castillo L, de la Cuétara K, Macías R.
    Rev Neurol; 1998 Mar 23; 26(151):361-5. PubMed ID: 9585942
    [Abstract] [Full Text] [Related]

  • 16. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
    Smith AD, Kozlowski DA, Bohn MC, Zigmond MJ.
    Exp Neurol; 2005 Jun 23; 193(2):420-6. PubMed ID: 15869944
    [Abstract] [Full Text] [Related]

  • 17. Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission.
    Andersson DR, Nissbrandt H, Bergquist F.
    Eur J Neurosci; 2006 Jul 23; 24(2):617-24. PubMed ID: 16903863
    [Abstract] [Full Text] [Related]

  • 18. Repeated amphetamine administration: role of forebrain in reduced responsiveness of nigrostriatal dopamine neurons to dopamine agonists.
    Pitts DK, Kelland MD, Freeman AS, Chiodo LA.
    J Pharmacol Exp Ther; 1993 Feb 23; 264(2):616-21. PubMed ID: 8094749
    [Abstract] [Full Text] [Related]

  • 19. Acute and chronic haloperidol treatment: effects on nigrostriatal dopaminergic system activity.
    Bunney BS, Skirboll LR, Grace AA.
    Adv Biochem Psychopharmacol; 1980 Feb 23; 24():267-73. PubMed ID: 7405666
    [No Abstract] [Full Text] [Related]

  • 20. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
    Choi-Lundberg DL, Lin Q, Schallert T, Crippens D, Davidson BL, Chang YN, Chiang YL, Qian J, Bardwaj L, Bohn MC.
    Exp Neurol; 1998 Dec 23; 154(2):261-75. PubMed ID: 9878166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.